Your browser doesn't support javascript.
loading
Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment.
Tharp, Kevin M; Kersten, Kelly; Maller, Ori; Timblin, Greg A; Stashko, Connor; Canale, Fernando P; Menjivar, Rosa E; Hayward, Mary-Kate; Berestjuk, Ilona; Ten Hoeve, Johanna; Samad, Bushra; Ironside, Alastrair J; di Magliano, Marina Pasca; Muir, Alexander; Geiger, Roger; Combes, Alexis J; Weaver, Valerie M.
Afiliación
  • Tharp KM; Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Kersten K; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  • Maller O; ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA.
  • Timblin GA; Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Stashko C; Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Canale FP; Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Menjivar RE; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Hayward MK; Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Berestjuk I; Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Ten Hoeve J; Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Samad B; UCLA Metabolomics Center, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Ironside AJ; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
  • di Magliano MP; ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA.
  • Muir A; UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA.
  • Geiger R; Department of Pathology, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Combes AJ; Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Weaver VM; Department of Cell and Developmental Biology, Cancer Biology Program, University of Michigan, Ann Arbor, MI, USA.
Nat Cancer ; 2024 Jun 03.
Article en En | MEDLINE | ID: mdl-38831058
ABSTRACT
Tumor progression is accompanied by fibrosis, a condition of excessive extracellular matrix accumulation, which is associated with diminished antitumor immune infiltration. Here we demonstrate that tumor-associated macrophages (TAMs) respond to the stiffened fibrotic tumor microenvironment (TME) by initiating a collagen biosynthesis program directed by transforming growth factor-ß. A collateral effect of this programming is an untenable metabolic milieu for productive CD8+ T cell antitumor responses, as collagen-synthesizing macrophages consume environmental arginine, synthesize proline and secrete ornithine that compromises CD8+ T cell function in female breast cancer. Thus, a stiff and fibrotic TME may impede antitumor immunity not only by direct physical exclusion of CD8+ T cells but also through secondary effects of a mechano-metabolic programming of TAMs, which creates an inhospitable metabolic milieu for CD8+ T cells to respond to anticancer immunotherapies.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos